Editorial: Inflammation, Metabolism and Epigenetics in Valvular Heart Disease

Eva  Jover; Ashton R M Faulkner; Paolo R Madeddu; Natalia  López-Andrés

doi:10.3389/fcvm.2022.880015

Editorial: Inflammation, Metabolism and Epigenetics in Valvular Heart Disease

Eva Jover^*, Ashton R M Faulkner, Paolo R Madeddu, Natalia López-Andrés

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

38 Downloads (Pure)

Original language	English
Article number	880015
Number of pages	3
Journal	Frontiers in Cardiovascular Medicine
Volume	9
DOIs	https://doi.org/10.3389/fcvm.2022.880015
Publication status	Published - 11 Apr 2022

Bibliographical note

Funding Information:
This work was supported by a Sara Borrell grant (CD19/00251) from the Instituto de Salud Carlos III by a Miguel Servet contract CP13/00221 from the Instituto de Salud Carlos 674 III-FEDER, Fondo de Investigaciones Sanitarias (PI18/01875), and by the British Heart Foundation (BHF) Centre for Cardiovascular Regenerative Medicine Award (II)-Centre for Vascular Regeneration (RM/17/3/33381).

Keywords

valvular heart disease
inflammation
metabolism
sex-differences
epigenetics
non-coding RNA
biomarkers

Access to Document

10.3389/fcvm.2022.880015Licence: CC BY

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Frontiers Media at https://doi.org/10.3389/fcvm.2022.880015. Please refer to any applicable terms of use of the publisher.
Final published version, 113 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{e239a67784d74d68866fc1e579f3d670,

title = "Editorial: Inflammation, Metabolism and Epigenetics in Valvular Heart Disease",

keywords = "valvular heart disease, inflammation, metabolism, sex-differences, epigenetics, non-coding RNA, biomarkers",

author = "Eva Jover and Faulkner, {Ashton R M} and Madeddu, {Paolo R} and Natalia L{\'o}pez-Andr{\'e}s",

note = "Funding Information: This work was supported by a Sara Borrell grant (CD19/00251) from the Instituto de Salud Carlos III by a Miguel Servet contract CP13/00221 from the Instituto de Salud Carlos 674 III-FEDER, Fondo de Investigaciones Sanitarias (PI18/01875), and by the British Heart Foundation (BHF) Centre for Cardiovascular Regenerative Medicine Award (II)-Centre for Vascular Regeneration (RM/17/3/33381). ",

year = "2022",

month = apr,

day = "11",

doi = "10.3389/fcvm.2022.880015",

language = "English",

volume = "9",

journal = "Frontiers in Cardiovascular Medicine",

issn = "2297-055X",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Editorial

T2 - Inflammation, Metabolism and Epigenetics in Valvular Heart Disease

AU - Jover, Eva

AU - Faulkner, Ashton R M

AU - Madeddu, Paolo R

AU - López-Andrés, Natalia

N1 - Funding Information: This work was supported by a Sara Borrell grant (CD19/00251) from the Instituto de Salud Carlos III by a Miguel Servet contract CP13/00221 from the Instituto de Salud Carlos 674 III-FEDER, Fondo de Investigaciones Sanitarias (PI18/01875), and by the British Heart Foundation (BHF) Centre for Cardiovascular Regenerative Medicine Award (II)-Centre for Vascular Regeneration (RM/17/3/33381).

PY - 2022/4/11

Y1 - 2022/4/11

KW - valvular heart disease

KW - inflammation

KW - metabolism

KW - sex-differences

KW - epigenetics

KW - non-coding RNA

KW - biomarkers

U2 - 10.3389/fcvm.2022.880015

DO - 10.3389/fcvm.2022.880015

M3 - Article (Academic Journal)

C2 - 35479274

SN - 2297-055X

VL - 9

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

M1 - 880015

ER -